On August 24, 2022 Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, reported that its management team will participate in the following upcoming investor conferences (Press release, Arcus Biosciences, AUG 24, 2022, View Source [SID1234618618]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Citi 17th Annual BioPharma Conference
Date: Wednesday, September 7th, 2022
Location: Boston, MA
Format: 1-on-1 meetings only
Morgan Stanley 20th Annual Global Healthcare Conference
Date: Monday, September 12th , 2022 at 12:30 p.m. ET
Location: New York, NY
Format: Fireside Chat
A live webcast of the fireside chat will be available by visiting the "Investors & Media" section of the Arcus Biosciences website at www.arcusbio.com. A replay of the webcast will be available following the live event.